Abstract:Obesity is an increasingly prevalent disease regulated by genetic and environmental factors. Emerging studies indicate that immune cells, including monocytes, granulocytes and lymphocytes, regulate metabolic homeostasis and are dysregulated in obesity. Group 2 innate lymphoid cells (ILC2s) can regulate adaptive immunity and eosinophil and alternatively activated macrophage responses, and were recently identified in murine white adipose tissue (WAT) where they may act to limit the development of obesity. However, ILC2s have not been identified in human adipose tissue, and the mechanisms by which ILC2s regulate metabolic homeostasis remain unknown. Here we identify ILC2s in human WAT and demonstrate that decreased ILC2 responses in WAT are a conserved characteristic of obesity in humans and mice. Interleukin (IL)-33 was found to be critical for the maintenance of ILC2s in WAT and in limiting adiposity in mice by increasing caloric expenditure. This was associated with recruitment of uncoupling protein 1 (UCP1)(+) beige adipocytes in WAT, a process known as beiging or browning that regulates caloric expenditure. IL-33-induced beiging was dependent on ILC2s, and IL-33 treatment or transfer of IL-33-elicited ILC2s was sufficient to drive beiging independently of the adaptive immune system, eosinophils or IL-4 receptor signalling. We found that ILC2s produce methionine-enkephalin peptides that can act directly on adipocytes to upregulate Ucp1 expression in vitro and that promote beiging in vivo. Collectively, these studies indicate that, in addition to responding to infection or tissue damage, ILC2s can regulate adipose function and metabolic homeostasis in part via production of enkephalin peptides that elicit beiging.

Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity

Activated type 2 innate lymphoid cells regulate beige fat biogenesis

A Heterogeneous Lineage Origin Underlies the Phenotypic and Molecular Differences of White and Beige Adipocytes

Innate lymphoid cells type 2 - emerging immune regulators of obesity and atherosclerosis

ILC2s Control Obesity by Regulating Energy Homeostasis and Browning of White Fat

Adipose Group 1 Innate Lymphoid Cells Promote Adipose Tissue Fibrosis and Diabetes in Obesity

ILC2s Improve Glucose Metabolism Through the Control of Saturated Fatty Acid Absorption Within Visceral Fat

Interleukin-33 and Interferon-γ Counter-Regulate Group 2 Innate Lymphoid Cell Activation during Immune Perturbation

IL-27 signalling promotes adipocyte thermogenesis and energy expenditure

Innate Lymphoid Cells in the Induction of Obesity

Fibroblastic reticular cells in lymph node potentiate white adipose tissue beiging through neuro-immune crosstalk in male mice

IL-25–induced shifts in macrophage polarization promote development of beige fat and improve metabolic homeostasis in mice

Anabolic lipid metabolism regulates adipose type 2 innate lymphoid cell differentiation to maintain metabolic health

Eosinophils and Type 2 Cytokine Signaling in Macrophages Orchestrate Development of Functional Beige Fat.

Macrophage-derived chemokine CCL22 establishes local LN-mediated adaptive thermogenesis and energy expenditure

PD-1 is Involved in the Dysregulation of Type 2 Innate Lymphoid Cells in a Murine Model of Obesity

An immune-beige adipocyte communication via nicotinic acetylcholine receptor signaling

Modulation of the IL-33/IL-13 Axis in Obesity by IL-13Rα2

Leptin and Insulin Act on POMC Neurons to Promote the Browning of White Fat

Mast Cells Promote Seasonal White Adipose Beiging in Humans

IL-6 Regulates M2 Polarization and Local Proliferation of Adipose Tissue Macrophages in Obesity